240 related articles for article (PubMed ID: 35611551)
1. The association of six autoimmune bullous diseases with thyroid disorders: a population-based study.
Kridin K; Hübner F; Linder R; Schmidt E
J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):1826-1830. PubMed ID: 35611551
[TBL] [Abstract][Full Text] [Related]
2. The burden of neurological comorbidities in six autoimmune bullous diseases: a population-based study.
Kridin K; Hübner F; Recke A; Linder R; Schmidt E
J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):2074-2078. PubMed ID: 34153122
[TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of autoimmune bullous diseases in Middle Franconia.
Sollfrank L; Schönfelder V; Sticherling M
Front Immunol; 2023; 14():1256617. PubMed ID: 37881435
[TBL] [Abstract][Full Text] [Related]
4. Pruritus Is Associated with an Increased Risk for the Diagnosis of Autoimmune Skin Blistering Diseases: A Propensity-Matched Global Study.
Raap U; Limberg MM; Kridin K; Ludwig RJ
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979421
[TBL] [Abstract][Full Text] [Related]
5. The pathogeneses of pemphigus and pemphigoid diseases.
Ujiie H; Yamagami J; Takahashi H; Izumi K; Iwata H; Wang G; Sawamura D; Amagai M; Zillikens D
J Dermatol Sci; 2021 Dec; 104(3):154-163. PubMed ID: 34916040
[TBL] [Abstract][Full Text] [Related]
6. A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy.
Kianfar N; Dasdar S; Daneshpazhooh M; Aryanian Z; Goodarzi A
Exp Dermatol; 2023 Jul; 32(7):934-944. PubMed ID: 37150538
[TBL] [Abstract][Full Text] [Related]
7. Neonatal Autoimmune Blistering Disease: A Systematic Review.
Zhao CY; Chiang YZ; Murrell DF
Pediatr Dermatol; 2016 Jul; 33(4):367-74. PubMed ID: 27086740
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Autoimmune Bullous Diseases in Elderly Patients in Iran: A 10-Year Retrospective Study.
Ghiasi M; Daneshpazhooh M; Ismonov M; Chams-Davatchi C
Skinmed; 2017; 15(3):175-180. PubMed ID: 28705276
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of autoimmune bullous diseases in Iran: a 10-year review.
Daneshpazhooh M; Chams-Davatchi C; Payandemehr P; Nassiri S; Valikhani M; Safai-Naraghi Z
Int J Dermatol; 2012 Jan; 51(1):35-41. PubMed ID: 22182376
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of Autoimmune Bullous Diseases in Northern Greece. A 4-year Retrospective Study and Review of the Literature.
Patsatsi A; Lamprou F; Kokolios M; Stylianidou D; Trigoni A; Kalampalikis D; Sotiriadis D
Acta Dermatovenerol Croat; 2017 Oct; 25(3):195-201. PubMed ID: 29252171
[TBL] [Abstract][Full Text] [Related]
11. Blistering diseases in the mature patient.
Lakoš Jukić I; Jerković Gulin S; Marinović B
Clin Dermatol; 2018; 36(2):231-238. PubMed ID: 29566927
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of autoimmune bullous diseases and therapeutic modalities during a 10 year period in Iran.
Jowkar F; Sadati MS; Tavana S; Agah MA
Acta Dermatovenerol Croat; 2014; 22(4):246-9. PubMed ID: 25580783
[TBL] [Abstract][Full Text] [Related]
13. Involvement of palms and soles in patients with autoimmune bullous diseases: a comparative analysis of a diagnostically relevant localization.
Jałowska M; Spałek M; Bowszyc-Dmochowska M; Gornowicz-Porowska J; Dmochowski M
Front Immunol; 2023; 14():1227855. PubMed ID: 37885886
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of autoimmune bullous diseases in Sudan between 2000 and 2016.
Siddig O; Mustafa MB; Kordofani Y; Gibson J; Suleiman AM
PLoS One; 2021; 16(7):e0254634. PubMed ID: 34255799
[TBL] [Abstract][Full Text] [Related]
15. High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases.
Segura S; Iranzo P; Martínez-de Pablo I; Mascaró JM; Alsina M; Herrero J; Herrero C
J Am Acad Dermatol; 2007 Jun; 56(6):960-7. PubMed ID: 17368865
[TBL] [Abstract][Full Text] [Related]
16. [Bullous autoimmune dermatoses of the mucous membranes].
Didona D; Hinterseher J; Eming R
Dermatologie (Heidelb); 2022 Sep; 73(9):692-700. PubMed ID: 36006424
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of Autoimmune Bullous Diseases in the Middle East: A 15-Year Review.
Haber R; Helou J; Habr C; Tomb R
Skinmed; 2017; 15(3):181-186. PubMed ID: 28705277
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune bullous skin diseases. Part 1: Clinical manifestations.
Kneisel A; Hertl M
J Dtsch Dermatol Ges; 2011 Oct; 9(10):844-56; quiz 857. PubMed ID: 21955378
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune bullous diseases associations.
Ljubojevic S; Lipozenčić J
Clin Dermatol; 2012; 30(1):17-33. PubMed ID: 22137223
[TBL] [Abstract][Full Text] [Related]
20. Expression of the alpha 6 beta 4 integrin in lesional skin differentiates bullous pemphigoid (BP) from epidermolysis bullosa acquisita (EBA).
Michalaki H; Staquet MJ; Cerri A; Berti E; Roche P; Machado P; Nicolas JF
J Invest Dermatol; 1992 Feb; 98(2):204-8. PubMed ID: 1732384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
